A Novel Strategy for P. falciparum Malaria based on Syk Kinase Inhibitors to Design Triple Artemisininbased Combination Therapies (TACTs) to Counteract Delayed Parasite Clearance (Drug Resistance) Following Standard ACT Treatment
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.